Navigation Links
Watson Presents Outlook for Continued Long Term Growth
Date:1/21/2011

products; and such other risks and uncertainties detailed in Watson's Annual Report on Form 10-K for the year ending December 31, 2009, Watson's Form 10-Q for the quarter ending September 30, 2010 and other company filings with the Securities and Exchange Commission.

Trademarks in this press release are the property of their respective registered owners.

The following table presents a reconciliation of forecasted net income for the twelve months ending December 31, 2011 to adjusted net income and adjusted earnings per diluted share: Forecast for Twelve MonthsEnding December 31, 2011LowHighGAAP to Adjusted cash net income calculationGAAP net income

$  278$
316Adjusted for:Amortization

200200Acquisition and licensing charges

6464Global supply chain initiative

1010Legal settlements

--Loss on asset sales/impairment

--Gain on security sales

--Income taxes

(69)(69)Adjusted cash net income

$  483$
521Diluted earnings per shareDiluted earnings per share - GAAP

$ 2.21$
2.52Diluted earnings per share - Cash

$ 3.85$
4.15Diluted weighted average common shares outstanding

125.6125.6The reconciliation table is based in part on management's estimate of adjusted cash net income for the year ending December 31, 2011. Watson expects certain known GAAP charges for 2011, as presented in the schedule above. Other GAAP charges that may be excluded from adjusted cash net income are possible, but their amounts are dependent on numerous factors that we currently cannot ascertain with sufficient certainty or are presently unknown. These GAAP charges, such as potential asset impairment charges, are dependent upon future events and valuations that have not yet been performed.

The following table presents a reconciliation of forecasted net income for the twelve months ending December 31, 2011 to adjusted EBITDA: Forecast for Twelve MonthsEnding December 31, 2011LowH
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Reportlinker Adds Watson Pharmaceuticals Inc.: PharmaVitae Profile
2. Watson Announces Preliminary Financial Performance for FY 2010
3. Watson to Host Investor Day on January 21 in New York City
4. Watsons Generic Fentora® Receives FDA Approval
5. Watson to Present at the 29th Annual JP Morgan Healthcare Conference
6. Watson Announces Novel Oral Contraceptive Approval
7. Watson and Richter Announce Exclusive License Agreement for Esmya™
8. Watson Confirms Exalgo™ Patent Challenge
9. Watson Announces Pricing of Secondary Offering By Selling Stockholder
10. Watson Announces Commencement of Secondary Offering by Selling Stockholder
11. Watson To Present At The 2010 Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015  Cumberland Pharmaceuticals Inc. (NASDAQ: ... hospital acute care and gastroenterology, today announced fourth ... revenue grew 15% in 2014 to $37 million, ... $0.35 per diluted share. At the end of ... million including $55 million in cash and investments, ...
(Date:3/3/2015)... 2015   Surefire Medical, Inc. today ... the Surefire Infusion System with an end hole ... liver cancer, using the Surefire resulted in statistically ... and with significantly decreased uptake in normal liver ... Society of Interventional Radiology (SIR) meeting ...
(Date:3/3/2015)... , March 3, 2015  UnaliWear announces the ... advanced support for seniors that guards against wandering and ... The new wearable – the Kanega watch ( ... kind to use an easy speech interface rather than ... information without human input. The watch ...
Breaking Medicine Technology:Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 2Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 3Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 4Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 5Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 6Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 7Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 8Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 9Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 10Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 11Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 12Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 13Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 14Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 15Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 16Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 17Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 18Clinical Trial Comparing the Surefire Infusion Device to an End Hole Catheter Finds Surefire Increases Tumor Uptake and Decreases Non-Target Embolization In Every Patient, Multiple Liver Cancer Types 2UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2
... SPRING, Md., Jan. 13, 2011 FDA has taken new ... with use of the pain- and fever reducing drug acetaminophen. ... steps include asking makers of prescription products that contain acetaminophen ... tablet or capsule. Learn more about FDA,s measures, ...
... Inc. (OTCQB: SCLR) today announced that its common stock is ... beginning January 13, 2011 under the trading symbol ,SCLR,.  The ... Bulletin Board and OTCQB™ Market on that date.  SCOLR,s common ... the close of business on January 12, 2011. ...
Cached Medicine Technology:SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011 2
(Date:3/4/2015)... D.C. (PRWEB) March 04, 2015 From ... Professionals (IAPP) Global Privacy Summit 2015 , AvePoint, ... platforms and devices, today introduced the AvePoint Risk ... the complete lifecycle of risk across the enterprise. , ... AvePoint Privacy Impact Assessment (APIA) system – ...
(Date:3/4/2015)... Chicago (PRWEB) March 04, 2015 Professionals ... want more targeted outreach from companies, according to a ... December 2014 survey of 235 professionals with disabilities ... more online job search tools, including ones that are ... meaningful work. Some highlights:, ,     Online job ...
(Date:3/4/2015)... March 04, 2015 Parkview Regional ... that Alan Daugherty has been named chief executive ... has served as interim CEO of Parkview Regional ... has provided tremendous leadership during his tenure as ... hospital strategy and developing relationships with physicians, patients ...
(Date:3/3/2015)... MED-Ed Facilities Boston , the ... for New England, April 7+8, 2015 at the ... related workshops. Sessions offer LUs and several have ... Curtain Walls for Labs and Medical Facilities, Curtain ... facilities are often required to meet more demanding ...
(Date:3/3/2015)... On February 24, 2015, a Toledo, Ohio homeowner ... Court for the Northern District of Ohio against mortgage ... companies Balboa, QBE, and Newport Management. (See Amended Complaint ... The Plaintiff, a Ms. Dolores Gorsuch, says her mortgage ... buy too much insurance at rates that were too ...
Breaking Medicine News(10 mins):Health News:AvePoint Unveils New Solution to Address the Complete Risk Lifecycle at IAPP Global Privacy Summit 2015 2Health News:AvePoint Unveils New Solution to Address the Complete Risk Lifecycle at IAPP Global Privacy Summit 2015 3Health News:AvePoint Unveils New Solution to Address the Complete Risk Lifecycle at IAPP Global Privacy Summit 2015 4Health News:Job Seekers with Disabilities Seek Targeted Outreach from Employers and Online Job Search Tools, says New Think Beyond The Label Survey 2Health News:Job Seekers with Disabilities Seek Targeted Outreach from Employers and Online Job Search Tools, says New Think Beyond The Label Survey 3Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 2Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 3Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 2Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 3Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 4Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 5Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 6Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2
... will issue a new 16-page report on FRAX to ... report is available at http://www.iofbonehealth.org/publications/frax.html ... free online tool developed by the World Health Organization ... better identify women and men in need of intervention ...
... (DKC) is an autosomal dominant disease that leads to abnormalities ... nails, bone marrow, lungs and gut. Patients with DKC experience ... fatal infections and cancer. Many die before the age of ... to treat its symptoms. At the heart of DKC is ...
... Study led by St. Jude Children,s Research Hospital ... with Down syndrome, fueling hope for new treatment ... new chromosomal abnormality in acute lymphoblastic leukemia (ALL) that ... give rise to cancer. This latest anomaly is particularly ...
... and relaxation exercises can help cut the pain, experts say , ... run away from an injection, so it,s no surprise that children ... it,s time for flu shots this year. , "The good ... to positively impact their child,s experience when getting a needlestick -- ...
... likely the pain, says research led by an 11-year-old, , SATURDAY, ... more than an hour a day increase their chances of having ... lead author of the study knows this all too well. Deniz ... pain among his classmates at Rossman Elementary in St. Louis, Mo., ...
... TSX: COM, , VANCOUVER, Oct. 16 /PRNewswire-FirstCall/ ... ("Cardiome" or the "Company") announced the final results of its modified ... million of its common shares (the "Offer"), which expired at 5:00 ... of its common shares for purchase and cancellation at a purchase ...
Cached Medicine News:Health News:New IOF report explains importance of FRAX in osteoporosis management 2Health News:Mice regain ability to extend telomeres suggesting potential for dyskeratosis congenita therapy 2Health News:New Chromosomal Abnormality Identified in Leukemia Associated with Down Syndrome 2Health News:New Chromosomal Abnormality Identified in Leukemia Associated with Down Syndrome 3Health News:New Chromosomal Abnormality Identified in Leukemia Associated with Down Syndrome 4Health News:Video Games Can Play Havoc With Kids' Joints 2Health News:Video Games Can Play Havoc With Kids' Joints 3Health News:Cardiome Pharma Corp. Announces Final Results of Tender Offer 2Health News:Cardiome Pharma Corp. Announces Final Results of Tender Offer 3Health News:Cardiome Pharma Corp. Announces Final Results of Tender Offer 4
... 1000 Power Instrument System is a small ... with modular and unitized handpieces.,The head modules ... or pneumatic motor, giving you the flexibility ... the motor. Now you can add instruments ...
... power line from MicroAire. Our new ... electric instruments, offering the ultimate in ... has always wanted with the security ... Power Master oscillating saw, Available with ...
... Saw offers unparalleled power for ... its 14.4V NiMH Rechargeable Battery ... be rotated into 12 positions ... and will accept any of ...
... consists of a pistol-grip handpiece available in ... wide range of couplers that can be ... applications., ,The Battery SmartDriver XT offers ... the original Battery SmartDriver. The Battery SmartDriver ...
Medicine Products: